Home › Kanser sa Esophagus › Virginia › Arlington

Pag-aaral pangklinika para sa Kanser sa Esophagus sa Arlington, VA

Isang pag-aaral para sa Kanser sa Esophagus ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Vanguard Study: Testing a New Way to Screen for Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Nagre-recruitPhase 1

Site 04, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07814248

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Nagre-recruitPhase 1

Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi ang layo
Inova Schar Cancer, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07519655

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Nagre-recruitPhase 3

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Nagre-recruitPhase 1

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227168

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Clinical Trial Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Nagre-recruitPhase 1

Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

Pag-aaral para sa Kanser sa Esophagus sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.